Search

everythinglearnresearchcommunity

for

Search:↓

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Skin diseases have a small to moderate impact on the quality of life of patients in Goa, India.

Intralesional triamcinolone acetonide is more effective but has a higher relapse rate than platelet-rich plasma for treating alopecia areata.

Finasteride is more effective and satisfactory than montelukast for treating moderate acne in women.

Teriflunomide often causes mild to moderate hair thinning and loss in MS patients, which usually improves with or without treatment.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Calcipotriol cream can effectively and safely treat mild-to-moderate patchy hair loss.

Low-dose radiation therapy may improve brain function in some Alzheimer's patients and is generally well-tolerated.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

Using fractional CO2 laser with halometasone cream works better for chronic hand eczema than just the cream, improving symptoms and quality of life with fewer relapses.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

12.5% of women with PCOS experience moderate hair loss, highlighting the need for early detection and management.

Finasteride effectively treats mild to moderate hair loss in men aged 18-41, with some side effects.

The compound zishenqing formula is effective and safe for treating mild to moderate systemic lupus erythematosus.

Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.

Nursing students in Turkey have a moderate acceptance of cosmetic surgery, influenced by education, urban background, personal connections to those who had surgery, perception of risk, and desire for awareness training.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Sodium selenate was found to be safe and possibly slows Alzheimer's progression, but more research is needed.

Finasteride gel and tablet both have similar moderate effects in treating male hair loss.

The oral contraceptive with ethinyl estradiol and chlormadinone acetate is effective in treating moderate acne.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

The new cream is safe and effective for mild to moderate atopic dermatitis.